The Italian Association of Medical Oncology (AIOM) has developed clinical practice guidelines for the treatment of patients with advanced non-small cell lung cancer (NSCLC). In the current paper a panel of AIOM experts in the field of thoracic malignancies discussed the available scientific evidences, with the final aim of providing a summary of clinical recommendations, which may guide physicians in their current practice.
Treatment of advanced non-small-cell lung cancer: The 2019 AIOM (Italian Association of Medical Oncology) clinical practice guidelines
Passiglia F.
Co-first
;Bertolaccini L.;Ramella S.;Novello S.
Last
;
2020-01-01
Abstract
The Italian Association of Medical Oncology (AIOM) has developed clinical practice guidelines for the treatment of patients with advanced non-small cell lung cancer (NSCLC). In the current paper a panel of AIOM experts in the field of thoracic malignancies discussed the available scientific evidences, with the final aim of providing a summary of clinical recommendations, which may guide physicians in their current practice.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Treatment of advanced non-small-cell lung cancer_ The 2019 AIOM (Italian Association of Medical Oncology) clinical practice guidelines.pdf
Accesso riservato
Tipo di file:
PDF EDITORIALE
Dimensione
938.19 kB
Formato
Adobe PDF
|
938.19 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
